Quality of life in carotid atherosclerosis: The role of co-morbid mood disorders

Clinical Practice and Epidemiology in Mental Health

Volumn 12, Issue , 2016, Pages 1-8

  Lecca, Maria ^a   Saba, Luca ^b   Sanfilippo, Roberto ^c   Pintus, Elisa ^a   Cadoni, Michela ^a   Sancassiani, Federica ^a   Moro, Maria Francesca ^a   Craboledda, Davide ^c   Giudice, Chiara Lo ^c   Montisci, Roberto ^c  

^a Azienda Ospedaliero Universitaria ^*  (Italy)

^b Azienda Ospedaliero Universitaria (AOU)   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Bipolar disorder; Carotid atherosclerosis; Major depressive disorder; Mood disorders; Quality of life

Indexed keywords

AGED; ARTICLE; BIPOLAR DISORDER; CAROTID ATHEROSCLEROSIS; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC DISEASE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; DSM-IV; FEMALE; HEALTH SURVEY; HUMAN; MAJOR DEPRESSION; MALE; MOOD DISORDER; PSYCHIATRIC DIAGNOSIS; QUALITY OF LIFE; SEMI STRUCTURED INTERVIEW; SHORT FORM 12;

EID: 84969263293     PISSN: None     EISSN: 17450179     Source Type: Journal    
DOI: 10.2174/1745017901612010001     Document Type: Article

References (45)

1. Celermajer DS, Chow CK, Marijon E, Anstey NM, Woo KS. Cardiovascular Disease in the Developing World Prevalences, Patterns, and the Potential of Early Disease Detection. J Am Coll Cardiol 2012; 60(14): 1207-16. [http://dx.doi.org/10.1016/j.jacc.2012.03.074]
2. Lloyd-Jones D, Adams RJ, Brown TM, et al. Executive summary: heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation 2010; 121(7): 948-54. [http://dx.doi.org/10.1161/CIRCULATIONAHA.109.192666]
3. Carta MG, Pala AN, Finco G, Musu M, Moro MF. Depression and cerebrovascular disease: could vortioxetine represent a valid treatment option? Clin Pract Epidemol Ment Health 2015; 11: 144-9. [http://dx.doi.org/10.2174/1745017901511010144]
4. Brott TG, Halperin JL, Abbara S, et al. ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Circulation 2011; 124(4): e54-e130.
5. de Weerd M, Greving JP, Hedblad B, et al. Prediction of asymptomatic carotid artery stenosis in the general population: identification of high-risk groups. Stroke 2014; 45(8): 2366-71. [http://dx.doi.org/10.1161/STROKEAHA.114.005145]
6. Vallina-Victorero M, Vaquero F, Alvarez A, Ramos MJ, Vicente M, Alvarez J. Carotid bifurcation atherosclerosis in the over-65s: A prevalence study. J Cardiovasc Surg (Torino) 2008; 49(2): 207-11.
7. de Weerd M, Greving JP, Hedblad B, et al. Prevalence of asymptomatic carotid artery stenosis in the general population: An individual participant datameta-Analysis. Stroke 2010; 41(6): 1294-7. [http://dx.doi.org/10.1161/STROKEAHA.110.581058]
8. Morr S, Lin N, Siddiqui AH. Carotid artery stenting: current and emerging options. Med Devices (Auckl) 2014; 7: 343-55. [Published online 2014 October 20].
9. Gargiulo G, Tortora F, Cirillo M, et al. Unexpected preserved brain perfusion imaging despite severe and diffuse atherosclerosis of supraaortic trunks. Cardiovasc J Afr 2013; 23(3): 214-14.
10. Brott TG, Hobson RW II, Howard G, et al. Stenting versus endarterectomy for treatment of carotid-Artery stenosis. N Engl J Med 2010; 363(1): 11-23. [http://dx.doi.org/10.1056/NEJMoa0912321]
11. Constantinou J, Jayia P, Hamilton G. Best evidence for medical therapy for carotid artery stenosis. J Vasc Surg 2013; 58(4): 1129-39. [http://dx.doi.org/10.1016/j.jvs.2013.06.085]
12. Hadidi N, Treat-Jacobson DJ, Lindquist R. Poststroke depression and functional outcome: A critical review of literature. Heart Lung 2009; 38: 151-62. [http://dx.doi.org/10.1016/j.hrtlng.2008.05.002]
13. Roberts RE. Reliability of the CES-D Scale in different ethnic contexts. Psychiatry Res 1980; 2(2): 125-34. [http://dx.doi.org/10.1016/0165-1781(80)90069-4]
14. Tiemeier H, van Dijck W, Hofman A, Witteman JC, Stijnen T, Breteler MM. Relationship between atherosclerosis and late-life depression: The Rotterdam Study. Arch Gen Psychiatry 2004; 61(4): 369-76. [http://dx.doi.org/10.1001/archpsyc.61.4.369]
15. Haas DC, Davidson KW, Schwartz DJ, et al. Depressive symptoms are independently predictive of carotid atherosclerosis. Am J Cardiol 2005; 95(4): 547-50. [http://dx.doi.org/10.1016/j.amjcard.2004.10.032]
16. Elovainio M, Keltikangas-Järvinen L, Kivimäki M, et al. Depressive symptoms and carotid artery intima-media thickness in young adults: The Cardiovascular Risk in Young Finns Study. Psychosom Med 2005; 67(4): 561-7. [http://dx.doi.org/10.1097/01.psy.0000170340.74035.23]
17. Whipple MO, Lewis TT, Sutton-Tyrrell K, et al. Hopelessness, depressive symptoms, and carotid atherosclerosis in women: The Study of Women's Health Across the Nation (SWAN) heart study. A Stroke 2009; 40(10): 3166-72. [http://dx.doi.org/10.1161/STROKEAHA.109.554519]
18. Rice SC, Zonderman AB, Metter EJ, Najjar SS, Waldstein SR. Absence of relation between depressive symptoms and carotid intimal medial thickness in the Baltimore Longitudinal Study of Aging. Psychosom Med 2009; 71(1): 70-6. [http://dx.doi.org/10.1097/PSY.0b013e3181865f73]
19. Hamer M, Malan NT, Harvey BH, Malan L. Depressive symptoms and sub-clinical atherosclerosis in Africans: role of metabolic syndrome, inflammation and sympathoadrenal function. Physiol Behav 2011; 104(5): 744-8.[http://dx.doi.org/10.1016/j.physbeh.2011.07.024]
20. Lee YH, Shin MH, Choi JS, et al. Gender Differences in the Association between Depressive Symptoms and Carotid Atherosclerosis among Middle-Aged and Older Koreans: The Namwon Study. J Korean Med Sci 2014; 29(11): 1507-13. [http://dx.doi.org/10.3346/jkms.2014.29.11.1507]
21. Whooley MA, De JP, Vittinghoff E, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008; 300: 2379-88. [http://dx.doi.org/10.1001/jama.2008.711]
22. Vieweg WV, Julius DA, Fernandez A, et al. Treatment of depression in patients with coronary heart disease. Am J Med 2006; 119(7): 567-73. [http://dx.doi.org/10.1016/j.amjmed.2006.02.037]
23. Sneed JR, Culang-Reinlieb ME. The vascular depression hypothesis: An update. Am J Geriatr Psychiatry 2011; 19(2): 99-103. [http://dx.doi.org/10.1097/JGP.0b013e318202fc8a]
24. Alexopoulos GS, Kiosses DN, Choi SJ, et al. Frontal white matter microstructure and treatment response of late-life depression: A preliminary study. Am J Psychiatry 2002; 159: 1929-32. [http://dx.doi.org/10.1176/appi.ajp.159.11.1929]
25. Carta MG, Aguglia E, Bocchetta A, et al. The use of antidepressant drugs and the lifetime prevalence of major depressive disorders in Italy. Clin Pract Epidemol Ment Health 2010; 6: 94-100. [http://dx.doi.org/10.2174/1745017901006010094]
26. First M, Spitzer R, Gibbon M, Williams J. Structured clinical interview for DSM-IV axis I disorders, research version, non-patient edition (SCID-I/NP). New York: Biometrics Research, New York State Psychiatric Institute 1997.
27. Hardoy MC, Cadeddu M, Murru A, et al. Validation of the Italian version of the "Mood Disorder Questionnaire" for the screening of bipolar disorders. Clin Pract Epidemol Ment Health 2005; 1: 8. [http://dx.doi.org/10.1186/1745-0179-1-8]
28. Saba L, Anzidei M, Sanfilippo R, et al. Imaging of the carotid artery. Atherosclerosis 2012; 220(2): 294-309. [http://dx.doi.org/10.1016/j.atherosclerosis.2011.08.048]
29. Ware J Jr, Kosinski M, Keller SD. 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34(3): 220-33. [http://dx.doi.org/10.1097/00005650-199603000-00003]
30. Carta MG, Preti A, Moro MF, et al. Eating disorders as a public health issue: Prevalence and attributable impairment of quality of life in an Italian community sample. Int Rev Psychiatry 2014; 26(4): 486-92. [http://dx.doi.org/10.3109/09540261.2014.927753]
31. Carta MG, Moro MF, Lorefice L, et al. Multiple sclerosis and bipolar disorders: The burden of comorbidity and its consequences on quality of life. J Affect Disord 2014; 167C: 192-7. [http://dx.doi.org/10.1016/j.jad.2014.05.024]
32. Carta MG, Sorbello O, Moro MF, et al. Bipolar disorders and Wilson's disease. BMC Psychiatry 2012; 12(1): 52. [http://dx.doi.org/10.1186/1471-244X-12-52]
33. Carta MG, Moro MF, Aguglia E, et al. The attributable burden of panic disorder in the impairment of quality of life in a national survey in Italy. Int J Soc Psychiatry 2015; 0020764015573848. [Epub ahead of print].
34. Carta MG, Aguglia E, Caraci F, et al. Quality of life and urban /rural living: preliminary results of a community survey in Italy. Clin Pract Epidemol Ment Health 2012; 8: 169-74.[http://dx.doi.org/10.2174/1745017901208010169]
35. Carta MG, Carpiniello B, Kovess V, Porcedda R, Zedda A, Rudas N. Lifetime prevalence of major depression and dystymia. Eur Neuropsychopharmacol 1995; 5(Suppl.): 103-7. [http://dx.doi.org/10.1016/0924-977X(95)00036-O]
36. Hardoy MC, Carta MG, Marci AR, et al. Exposure to aircraft noise and risk of psychiatric disorder: The Elmas survey. Soc Psychiatry Psychiatr Epidemiol 2005; 40(1): 24-6. [http://dx.doi.org/10.1007/s00127-005-0837-x]
37. Fiedorowicz JG, Solomon DA, Endicott J, et al. Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder. Psychosom Med 2009; 71: 598-606. [http://dx.doi.org/10.1097/PSY. 0b013e3181acee26]
38. Weiner M, Warren L, Fiedorowicz JG. Cardiovascular morbidity and mortality in bipolar disorder. Ann Clin Psychiatry 2011; 23: 40-7.
39. Fiedorowicz JG, Coryell WH, Rice JP, Warren LL, Haynes WG. Vasculopathy related to manic/hypomanic symptom burden and firstgeneration antipsychotics in a sub-sample from the collaborative depression study. Psychother Psychosom 2012; 81: 235-43. [http://dx.doi.org/10.1159/000334779]
40. Chiarani F, Tramontina JF, Ceresér KM, et al. Homocysteine and other markers of cardiovascular risk during a manic episode in patients with bipolar disorder. Rev Bras Psiquiatr 2013; 35(2): 157-60. [http://dx.doi.org/10.1590/1516-4446-2012-0797]
41. Subramaniam H, Dennis MS, Byrne EJ. The role of vascular risk factors in late onset bipolar disorder. Int J Geriatr Psychiatry 2007; 22(8): 733-7. [http://dx.doi.org/10.1002/gps.1730]
42. Schoepf D, Heun R. Bipolar disorder and comorbidity: increased prevalence and increased relevance of comorbidity for hospital-based mortality during a 12.5-year observation period in general hospital admissions. J Affect Disord 2014; 169: 170-8. [http://dx.doi.org/10.1016/j.jad.2014.08.025]
43. Carta MG, Moro MF, Lorefice L, et al. The risk of Bipolar Disorders in Multiple Sclerosis. J Affect Disord 2014; 155: 255-60. c [http://dx.doi.org/10.1016/j.jad.2013.11.008]
44. Mantovani G, Astara G, Lampis B, et al. Evaluation by multidimensional instruments of health related quality of life of elderly cancer patients. Support Cancer Care 1996; 4: 129-40. [http://dx.doi.org/10.1007/BF01845762]
45. Mantovani G, Astara G, Lampis B, et al. Impact of psychosocial interventions on quality of life of elderly cancer patients. Psychooncology 1996; 5: 127-35. [http://dx.doi.org/10.1002/(SICI)1099-1611(199606) 5:23.0.CO;2-L]